Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial)
在日本临床环境中伊马替尼停药研究的可行性:欣喜地克服了 CML 专家停用 TKI 试验(DOMEST 试验)
期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-018-1368-2
Fujisawa, Shin; Ueda, Yasunori; Usuki, Kensuke; Kobayashi, Hajime; Kondo, Eisei; Doki, Noriko; Nakao, Takafumi; Kanda, Yoshinobu; Kosugi, Nobuharu; Kosugi, Hiroshi; Kumagai, Takashi; Harada, Hiroshi; Shikami, Masato; Maeda, Yasuhiro; Sakura, Toru; Inokuchi, Koiti; Saito, Akio; Nawa, Yuichiro; Ogasawara, Masahiro; Nishida, Junji; Kondo, Takeshi; Yoshida, Chikashi; Kuroda, Hiroyuki; Tabe, Yoko; Maeda, Yoshinobu; Imajo, Kenji; Kojima, Kensuke; Morita, Satoshi; Komukai, Sho; Kawaguchi, Atsushi; Sakamoto, Junichi; Kimura, Shinya